BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 27766540)

  • 1. Topical nonsteroidal anti-inflammatory drugs as adjuvant therapy in the prevention of macular edema after cataract surgery.
    Cardascia N; Palmisano C; Centoducati T; Alessio G
    Int Ophthalmol; 2017 Oct; 37(5):1127-1131. PubMed ID: 27766540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Efficacy of Dexamethasone, Nepafenac, and Bromfenac for Preventing Pseudophakic Cystoid Macular Edema: an Open-label, Prospective, Randomized Controlled Trial.
    Campa C; Salsini G; Perri P
    Curr Eye Res; 2018 Mar; 43(3):362-367. PubMed ID: 29120255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery.
    Miyake K; Ota I; Miyake G; Numaga J
    J Cataract Refract Surg; 2011 Sep; 37(9):1581-8. PubMed ID: 21855758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive Effect of Oral Steroid with Topical Nonsteroidal Anti-inflammatory Drug for Preventing Cystoid Macular Edema after Cataract Surgery in Patients with Epiretinal Membrane.
    Kim S; Kim MK; Wee WR
    Korean J Ophthalmol; 2017 Oct; 31(5):394-401. PubMed ID: 28913997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery.
    Lim BX; Lim CH; Lim DK; Evans JR; Bunce C; Wormald R
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD006683. PubMed ID: 27801522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1.
    Wielders LHP; Schouten JSAG; Winkens B; van den Biggelaar FJHM; Veldhuizen CA; Findl O; Murta JCN; Goslings WRO; Tassignon MJ; Joosse MV; Henry YP; Rulo AHF; Güell JL; Amon M; Kohnen T; Nuijts RMMA;
    J Cataract Refract Surg; 2018 Apr; 44(4):429-439. PubMed ID: 29778106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Comparative Efficacy and Tolerability of Diclofenac 0.1% and Bromfenac 0.09% Ophthalmic Solutions after Cataract Surgery.
    Giannaccare G; Finzi A; Sebastiani S; Greco F; Versura P; Campos EC
    Curr Eye Res; 2018 Dec; 43(12):1445-1453. PubMed ID: 30009640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenac.
    Wolf EJ; Braunstein A; Shih C; Braunstein RE
    J Cataract Refract Surg; 2007 Sep; 33(9):1546-9. PubMed ID: 17720068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasone 0.1%.
    Asano S; Miyake K; Ota I; Sugita G; Kimura W; Sakka Y; Yabe N
    J Cataract Refract Surg; 2008 Jan; 34(1):57-63. PubMed ID: 18165082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prednisolone versus dexamethasone for prevention of pseudophakic cystoid macular edema.
    Baartman BJ; Gans R; Goshe J
    Can J Ophthalmol; 2018 Apr; 53(2):131-134. PubMed ID: 29631823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraindividual comparison of nepafenac 0.3% for the prevention of macular edema after phacoemulsification.
    Tzelikis PF; Morato CS; Neves NT; Hida WT; Alves MR
    J Cataract Refract Surg; 2018 Apr; 44(4):440-446. PubMed ID: 29685777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postoperative management in cataract surgery: nepafenac and preservative-free diclofenac compared.
    Ylinen P; Taipale C; Lindholm JM; Laine I; Holmström E; Tuuminen R
    Acta Ophthalmol; 2018 Dec; 96(8):853-859. PubMed ID: 30284393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical non-steroidal anti-inflammatory drugs for the treatment of cystoid macular edema post Descemet's stripping automated endothelial keratoplasty.
    Kitazawa K; Kayukawa K; Wakimasu K; Inatomi T; Hieda O; Mori K; Sotozono C; Kinoshita S
    Jpn J Ophthalmol; 2018 Nov; 62(6):615-620. PubMed ID: 30255396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.
    Warren KA; Bahrani H; Fox JE
    Retina; 2010 Feb; 30(2):260-6. PubMed ID: 20175270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery.
    Almeida DR; Johnson D; Hollands H; Smallman D; Baxter S; Eng KT; Kratky V; ten Hove MW; Sharma S; El-Defrawy S
    J Cataract Refract Surg; 2008 Jan; 34(1):64-9. PubMed ID: 18165083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study.
    Tzelikis PF; Vieira M; Hida WT; Motta AF; Nakano CT; Nakano EM; Alves MR
    Br J Ophthalmol; 2015 May; 99(5):654-8. PubMed ID: 25385061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema.
    Mathys KC; Cohen KL
    Eye (Lond); 2010 Jan; 24(1):90-6. PubMed ID: 19229275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery.
    Zaczek A; Artzen D; Laurell CG; Stenevi U; Montan P
    J Cataract Refract Surg; 2014 Sep; 40(9):1498-505. PubMed ID: 25135542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery.
    Jung JW; Chung BH; Kim EK; Seo KY; Kim TI
    Yonsei Med J; 2015 Nov; 56(6):1671-7. PubMed ID: 26446653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New observation of microcystic macular edema as a mild form of cystoid macular lesions after standard phacoemulsification: Prevalence and risk factors.
    Yoon DH; Kang DJ; Kim MJ; Kim HK
    Medicine (Baltimore); 2018 Apr; 97(15):e0355. PubMed ID: 29642179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.